Tarlatamab

Imdelltra

1 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 28 Nov 2024

In other countries

The same active substances on other registers, the same brand first.

ImdelltraBrazil · Amgen Biotecnologia do Brasil Ltda.Same brand
Imdelltra Powder for Solution for Infusion 1 MG/VialSingapore · 1 mg/vial · injection, powder, lyophilized, for solution · Amgen Biotechnology Singapore Pte LTDSame brand
Imdelltra Powder for Solution for Infusion 10 MG/VialSingapore · 10 mg/vial · injection, powder, lyophilized, for solution · Amgen Biotechnology Singapore Pte LTDSame brand
ImdelltraUnited States · 10MG, 1MG · injectable · Amgen INCSame brand
Imdylltra 1 MG Polvo Para Concentrado y Solución Para Solucion Para PerfusionSpain · 1,34 mg · polvo para concentrado y solución para solución para perfusion · Amgen Europe B.V.Same substance
Imdylltra 10 MG Polvo Para Concentrado y Solucion Para Solucion Para Perfusion

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tarlatamab

Imdelltra

1 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 28 Nov 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Spain · Equivalente a 11,3 mg · polvo para concentrado y solución para solución para perfusion · Amgen Europe B.V.

ImdylltraEuropean Union · Amgen Europe B.V.

ImdylltraCroatia

ImdylltraItaly · polvere per concentrato e soluzione per soluzione per infusione · Amgen Europe B.V.

Imdylltra 1 mg poeder voor concentraat en oplossing voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Amgen Europe B.V.

Imdylltra 10 mg poeder voor concentraat en oplossing voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Amgen Europe B.V.

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tarlatamab
Strength: 1 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 28 Nov 2024
Registration: DIN 02551551
Marketing authorisation holder: Amgen Canada INC
ATC code: L01FX33
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D